Home » Generic and Specialty Pharmaceuticals (TRBC)
High U.S. share prices are pushing Lipper Award-winning equity fund managers into the shares of beaten-down healthcare companies, retailers and emerging-market stocks that they say offer a greater chance for outsized gains. More »
U.S. health regulators on Thursday approved a drug developed by Merck KGaA and Pfizer Inc that helps the immune system to fight a rare form of skin cancer once it has spread to other parts of the body. More »
A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease, according to data released on Sunday from a so-called real world study sponsored by AstraZeneca. More »
Patients who received Abbott Laboratories’ novel dissolving vascular stent had a significantly higher rate of serious adverse heart events than those treated with the company’s widely used Xience drug-coated metal stent two years after implantation, according ... More »
Longer-term use of the oral blood thinner Xarelto significantly cut the risk of recurrence of potentially life-threatening blood clots with no additional major bleeding compared with low-dose aspirin in patients at elevated risk, according to data presented on... More »
An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/File Photo Amgen Inc (AMGN.O) sells its cholesterol-lowering drug Repatha at a discount of about 30 percent to its U.S. list price of $1... More »
FILE PHOTO: The logo of AstraZeneca is seen on a medication package at a pharmacy in London April 28, 2014. REUTERS/Stefan Wermuth/File Photo AstraZeneca said on Friday that U.S. regulators had rejected the British company’s new drug for high potassium levels,... More »
FILE PHOTO – A sign for the headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec June 14, 2016. REUTERS/Christinne Muschi/File Photo ValueAct Capital raised its stake in Valeant Pharmaceuticals International Inc, in a move that co... More »
Developers of an experimental blood test for autism say it can detect the condition in more than 96 percent of cases and do so across a broad spectrum of patients, potentially allowing for earlier diagnosis, according to a study released on Thursday. More »
FILE PHOTO – William Ackman (L), chief executive of Pershing Square Capital, speaks with David Weinreb, CEO of Howard Hughes Corp. on the floor of the New York Stock Exchangein New York, U.S. on November 10, 2015. REUTERS/Brendan McDermid/File Photo Bayliss More »
FILE PHOTO – William Ackman, chief executive of Pershing Square walks on the floor of the New York Stock Exchange, New York, U.S. on November 10, 2015. REUTERS/Brendan McDermid/File Photo Bayliss and Michael Flaherty More »
Merck & Co Inc said on Tuesday it had got a nod from the U.S. Food and Drug Administration for its already-approved immunotherapy drug Keytruda as a treatment for a type of blood cancer. More »
The benefits of Endo International Plc’s long-acting opioid painkiller no longer outweigh its risks, an independent panel to the U.S. Food and Drug Administration (FDA) concluded on Tuesday. More »
A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble AstraZeneca’s ovarian cancer drug Lynparza slashed the risk of disease progression in a closely watched clinical trial, boosting its profile against rivals ... More »
Data that should help unlock the sales potential of a potent new cholesterol medicine will be unveiled at the American College of Cardiology meeting this week as the future of the only rival drug rests with the courts in an ongoing patent dispute. More »
FILE PHOTO – The logo of French drugmaker Sanofi is seen in front of the company’s headquarters in Paris, France, October 30, 2014. REUTERS/Christian Hartmann/File Photo Drugmakers Sanofi and Regeneron said on Saturday results from a one-year test of their Dup... More »
Bangladesh is to ban the import of the cold-medicine component pseudoephedrine, a key ingredient in illicit methamphetamine production, anti-narcotics officials said, after purchases spiked in tandem with a boom in the illegal drug “ya ba”. More »
The U.S. Food and Drug Administration said on Tuesday it had approved Lexicon Pharmaceuticals Inc’s oral drug to treat carcinoid syndrome diarrhea, a condition that develops in patients with gastrointestinal tumors. More »
FILE PHOTO – The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S., August 1, 2016. REUTERS/Andrew Kelly/File Photo The U.S. Food and Drug Administration said Pfizer Inc’s process for manufacturing sterile injectable drugs at a plant... More »
FILE PHOTO – The logo of French drugmaker Sanofi is seen in front of the company’s headquarters in Paris, France, October 30, 2014. REUTERS/Christian Hartmann/File Photo French drugmaker Sanofi and Swiss manufacturer Lonza will invest 270 million euros ($285 m... More »
FILE PHOTO — Shopping carts are seen outside a new Wal-Mart Express store in Chicago July 26, 2011. REUTERS/John Gress/File Photo Wal-Mart Stores Inc (WMT.N) is running a new price-comparison test in at least 1,200 U.S. stores and squeezing packaged goods supp... More »
A man walks past Pfizer’s world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File Photo Pfizer Inc said it received subpoenas from the U.S. Attorney’s Office for the District of Massachusetts related to its support for organizations that provi... More »
The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017. REUTERS/Arnd Wiegmann Swiss drugmaker Novartis’s drugs Tafinlar and Mekinist edged closer to approval in Europe to be used together against a type of lu... More »
President Donald Trump is interviewed by Reuters in the Oval Office at the White House in Washington, U.S., February 23, 2017. REUTERS/Jonathan Ernst U.S. President Donald Trump on Thursday spoke positively about a border adjustment tax being pushed by Republi... More »
People pack a glass bowl with marijuana during Hempfest’s 420Fest at the Luxe Nightclub in Seattle, Washington April 20, 2013. REUTERS/Nick Adams The administration of President Donald Trump may ramp up enforcement of federal laws against recreational marijuan... More »
Shelves displaying medicines are seen at a pharmacy in Shanghai, China November 27, 2015. REUTERS/Aly Song/File Photo China has updated list of medicines covered by basic medical insurance schemes, a long-awaited fillip for drugmakers in the world’s second-lar... More »
The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017. REUTERS/Arnd Wiegmann The U.S. Food and Drug Administration (FDA) has granted priority review to Novartis drug Zykadia as a first-line treatment for som... More »
Norwegian biotech newcomer Nordic Nanovector (NANOV.OL), which seeks ways to treat blood-related cancers, says other companies are showing interest in buying the firm. More »
U.S. President Donald Trump gestures as he leaves the podium after a news conference at the White House in Washington, U.S., February 16, 2017. REUTERS/Kevin Lamarque U.S. President Donald Trump’s choice to lead an important health agency said on Thursday that... More »
Berkshire Hathaway Inc Vice Chairman Charles Munger speaks at the Daily Journal annual meeting in Los Angeles, U.S., February 15, 2017. REUTERS/Lucy Nicholson Charlie Munger, the billionaire vice chairman of Warren Buffett’s Berkshire Hathaway Inc (BRKa.N), sa... More »
FILE PHOTO — A sign at the office building of health insurer Anthem is seen in Los Angeles, California February 5, 2015. REUTERS/Gus Ruelas/File Photo Anthem Inc said on Wednesday it has filed a lawsuit seeking to block smaller rival Cigna Corp from terminatin... More »
FILE PHOTO: Packets of Herceptin sit on a pharmacy shelf in London, Britiain, June 9, 2006. REUTERS/Luke MacGregor/File Photo Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche’s blood cancer drug Ri... More »
Warren Buffett, chairman and CEO of Berkshire Hathaway, smiles before speaking with Bill Gates (not pictured), at Columbia University in New York, U.S., January 27, 2017. REUTERS/Shannon Stapleton Warren Buffett’s Berkshire Hathaway Inc (BRKa.N) was an aggress... More »
A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo U.S. President Donald Trump’s vow to roll back government regulations at least 75 percent is causing anxiety for som... More »
Merck & Co Inc said on Tuesday it will halt a late-stage trial of an Alzheimer’s drug after it was determined that it had no chance of working, marking the latest in a long line of crushing disappointments in efforts to find an effective treatment for the mind... More »
Marathon Pharmaceuticals LLC said on Monday it was “pausing” the launch of its Duchenne muscular dystrophy drug after U.S. lawmakers questioned why the company priced it at $89,000 a year when patients had been able to import it for as little as $1,000. More »
FILE PHOTO – The Allergan logo is seen in this photo illustration in Singapore November 23, 2015. REUTERS/Thomas White/File Photo Botox maker Allergan Plc agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system that it says helps people ... More »
FILE PHOTO – The logo of French drugmaker Sanofi is seen in front of the company’s headquarters in Paris, France, October 30, 2014. REUTERS/Christian Hartmann/File Photo Drugmaker Ipsen (IPN.PA) has agreed to buy five consumer healthcare products from bigger F... More »
The logo of the pharmaceutical company Stada Arzneimittel AG is pictured at its headquarters in Bad Vilbel near Frankfurt March 14, 2012. REUTERS/Alex Domanski German generic drugmaker Stada (STAGn.DE) said it has received two offers for the acquisition of the... More »
Tetraphase Pharmaceuticals Inc Chief Executive Guy Macdonald said annual sales of the company’s lead experimental antibiotic for serious bacterial infections could climb as high as $700 million if approved. More »
French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo A U.S. appeals court on Wednesday stayed an order that would have blocked Regeneron Pharmaceuticals Inc and... More »
Two remaining late-stage clinical trials testing an experimental Alzheimer’s drug from Denmark’s Lundbeck have failed, scuppering hopes for the medicine and underscoring the difficulty of developing such treatments. More »
Mylan NV has agreed to pay $96.5 million to settle claims by drug purchasers that it delayed launching a generic version of Cephalon Inc’s narcolepsy drug Provigil in exchange for payment from Cephalon. More »
Express Scripts Holding Co, the largest pharmacy benefit manager in the United States, said prescription drug spending for its members slowed to less than 4 percent in 2016, at a time when scrutiny of drug price hikes has intensified. More »
Emma Walmsley of GlaxoSmithKline poses in this undated photograph released in London on September 20, 2016. Courtesy of GlaxoSmithKline/Handout via REUTERS Emma Walmsley, GlaxoSmithKline’s (GSK.L) incoming CEO, will take over Britain’s biggest drugmaker at a c... More »
A Swiss flag is pictured in front of the Federal Palace (Bundeshaus) is pictured in Bern, Switzerland, January 16, 2017. Picture taken on January 16, 2017. REUTERS/Denis Balibouse U.S. medical implant maker Zimmer Biomet’s (ZBH.N) decision on a potential $40 m... More »
Novo Nordisk, the world’s top maker of diabetes drugs, is investing 115 million pounds ($145 million) in a new research center in Britain, undeterred by Brexit. More »
U.S. President-elect Donald Trump sits with PayPal co-founder and Facebook board member Peter Thiel, Apple Inc CEO Tim Cook, Oracle CEO Safra Catz and Tesla Chief Executive Elon Musk during a meeting with technology leaders at Trump Tower in New York U.S., Dec... More »
Prescription painkiller oxycodone are shown at a pharmacy in Toronto, Ontario, Canada, January 17, 2017. Picture taken January 17, 2017. REUTERS/Hyungwon Kang As deaths from powerful painkillers continue to rise, Canada is pursuing unprecedented measures to cu... More »
Actelion’s Opsumit drug missed a primary endpoint in a late-stage study of patients with pulmonary arterial hypertension due to Eisenmenger Syndrome, a doctor involved in the trial said in a statement from the Swiss drugmaker. More »
Merck & Co said it agreed to enter into a settlement and license agreement with Bristol-Myers Squibb Co and Ono Pharmaceutical Co Ltd to resolve all global patent-infringement litigation related to its cancer drug, Keytruda. More »
Lee S. Ainslie III, founder of Maverick Capital speaks at the 6th Annual New York Value Investing Congress in New York City, October 12, 2010. REUTERS/Mike Segar Bayliss More »
Europe’s leading association of oncologists has thrown its weight behind cheaper copycat versions of biotech cancer drugs that have lost patent protection, saying they are effective and affordable. More »
Logos of Japanese Takeda Pharmaceutical Co are seen at an office building in Glattbrugg near Zurich March 7, 2012. REUTERS/Arnd Wiegmann/File Photo – RTX2RH16 Japan’s Takeda Pharmaceutical Co (4502.T) flagged its appetite for fresh acquisitions to bolster its ... More »
An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith Regeneron Pharmaceuticals Chief Executive Len Schleifer on Monday ripped into Amgen Inc for its insistence on blocking sales of a rival ... More »
The U.S. Food and Drug Administration on Monday approved Egalet Corp’s long-acting opioid painkiller, Arymo ER, and will allow the company to claim it deters abuse by those seeking to dissolve and inject it. More »
Kite Pharma Inc said on Monday it partnered with Daiichi Sankyo Co Ltd to develop and commercialize its cancer treatment therapy in Japan, putting the U.S. company in line to receive up to $250 million in payments. More »
A person holds pharmaceutical tablets and capsules in this picture illustration taken in Ljubljana September 18, 2013. REUTERS/Srdjan Zivulovic Last year turned out to be a disappointing one for new drug approvals with the U.S. Food and Drug Administration cle... More »
Arrangement of various world currencies including Chinese Yuan, US Dollar, Euro, British Pound, in this picture illustration taken January 25, 2011. REUTERS/Kacper Pempel/Illustration/File Photo Global equity raising fell by more than a quarter in 2016, data s... More »
Traders gather at the booth that trades Abbott Laboratories on the floor of the New York Stock Exchange, December 10, 2012. REUTERS/Brendan McDermid Healthcare company Abbott Laboratories (ABT.N) has won U.S. antitrust approval for its proposed $25 billion acq... More »
A woman talks on a mobile phone as she walks past the closed research facility of Semler Research Centre in Bengaluru, India, October 13, 2016. REUTERS/Abhishek N. Chinnappa Vasudeva Prakash left his job as a mechanic in Hyderabad three years ago for what he c... More »
Anthera Pharmaceuticals Inc said on Tuesday that its drug to treat certain cystic fibrosis patients failed a late-stage study, sending the company’s shares tumbling nearly 70 percent in after-hours trading. More »
An electoral poster of Donald Trump is displayed on the floor of the New York Stock Exchange (NYSE) the morning after the U.S. presidential election in New York City, U.S., November 9, 2016. REUTERS/Brendan McDermid For some equity funds and those betting on m... More »
An artificial leaf designed by scientists at Eindhoven University of Technology, Netherlands December 16, 2016. REUTERS/Jim Drury Dutch scientists have developed an artificial leaf that can act as a mini-factory for producing drugs, an advance that could allow... More »
Two U.S. lawmakers are questioning whether Heritage Pharmaceuticals misled them in response to a 2014 congressional inquiry about the rising price a common antibiotic, after 20 U.S. states this week accused the company of price fixing. More »
Indian generic drugmaker Laurus Labs Ltd’s shares rose as much as 16.36 percent on their market debut on Monday after the company’s initial public offering raised $196.6 million. More »
Hungarian pharmaceuticals firm Richter has withdrawn its marketing application for one of its biosimilar drugs from the European Medicines Agency in anticipation of a possible negative assessment, the company said on Monday. More »
German biotech firm Medigene said it is drawing more interest from prospective alliance partners for its technology to boost the immune response to cancer after its deal with U.S. peer Bluebird Bio. More »
Short seller Citron Research’s Andrew Left has turned his sights on Express Scripts Holding Co, calling the pharmacy benefit manager (PBM) the “culprit behind pharmaceutical price gouging.” More »
A screen displays trading information for stocks- Pfizer, Abbott Laboratories, Merck and Company and Eli Lilly and Company on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., May 16, 2016. REUTERS/Brendan McDermid/File Photo Two leading ... More »
A woman looks at a Center for Disease Control (CDC) health advisory sign about the dangers of the Zika virus as she lines up for a security screening at Miami International Airport in Miami, Florida, U.S., May 23, 2016. REUTERS/Carlo Allegri Texas health offic... More »
Four capules of Tamiflu are pictured on a Tamiflu box in Burbank, California, January 31, 2013. REUTERS/Fred Prouser The first generic copy of Roche’s top-selling flu pill Tamiflu hit the U.S. market on Monday, marking a further step in the Swiss drugmaker’s e... More »
The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel, Switzerland October 22, 2013. REUTERS/Arnd Wiegmann/File Photo Swiss drugmaker Novartis’s bid to bolster its eye drug portfolio suffered a setback on Monday when it announced combining ... More »
A logo is pictured on the laboratory building on the Lonza site in Visp, western Switzerland September 10, 2013. REUTERS/Denis Balibouse Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR &... More »
A promising but risky new group of customized cancer drugs will be in focus this weekend at the annual meeting of the American Society of Hematology (ASH), where clinical trial results will help clarify their potential for doctors and investors. More »
A Novartis logo is pictured on its headquarters building in Mumbai April 1, 2013. REUTERS/Vivek Prakash/File Photo An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form of blood cancer in 82 percent of children and young a... More »
A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed U.S regulators said on Friday they would allow Eli Lilly and Co to state that its diabetes drug Jardiance reduces risk of death... More »
A person holds pharmaceutical tablets and capsules in this picture illustration taken in Ljubljana September 18, 2013. REUTERS/Srdjan Zivulovic U.S. health spending in 2015 rose at its fastest rate since 2007, driven by expanded access to insurance under the A... More »
A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel February 17, 2015. REUTERS/Arnd Wiegmann Actelion (ATLN.S) has confirmed it has been approached by Johnson & Johnson (JNJ.N) about a possible transaction to take over the Sw... More »
A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel February 17, 2015. REUTERS/Arnd Wiegmann U.S. healthcare company Johnson & Johnson (JNJ.N) said on Friday it was in preliminary talks with Actelion (ATLN.S) about a potentia... More »
Herve Brailly, CEO of Innate Pharma, attends the Reuters Biotech summit in Paris June 3, 2009. REUTERS/John Schults France’s Innate Pharma believes that its cash position and portfolio are sufficiently robust for the cancer drug company to remain independent f... More »
The Google logo adorns the entrance of Google Germany headquarters in Hamburg, Germany July 11, 2016. Picture taken July 11, 2016. REUTERS/Morris Mac Matzen Novartis has abandoned a 2016 goal to start testing its autofocus contact lens on people, though it sai... More »
A woman stands near a poster explaining about the Zika virus at the Ministry of Health office in Jakarta, Indonesia September 2, 2016. REUTERS/Iqro Rinaldi/File Photo The World Health Organization on Friday declared that Zika no longer constitutes an internati... More »
Signage for GlaxoSmithKline is seen on it’s offices in London, Britain, March 30, 2016. REUTERS/Toby Melville/File Photo GlaxoSmithKline said on Monday it had filed its new three-in-one inhaled lung drug for U.S. approval, putting it on track to reach the mark... More »
The logo of Swiss pharmaceutical company Novartis is seen on its headquarters building in Basel, Switzerland October 27, 2015. REUTERS/Arnd Wiegmann Drugmaker Novartis (NOVN.S) is considering to sell its struggling Alcon eye care division, its chairman said in... More »
A company logo is seen at a Pfizer office in Dublin, Ireland November 24, 2015. REUTERS/Cathal McNaughton Pfizer Inc’s Celebrex arthritis drug was shown to be at least as safe as the widely used prescription-strength versions of painkillers ibuprofen and napro... More »
Signage for GlaxoSmithKline is seen on it’s offices in London, Britain, March 30, 2016. REUTERS/Toby Melville/File Photo The world’s top drugmakers have improved access to medicines in developing countries but still need to do more to make a wider range of pro... More »
A Novartis logo is pictured on its headquarters building in Mumbai April 1, 2013. REUTERS/Vivek Prakash/File Photo Novartis’s investigational drug PKC 412 won U.S. Food and Drug Administration priority review, the Swiss drugmaker said on Monday, keeping up mom... More »
Richter received a positive opinion from European regulators recommending that its generic osteoporosis drug Terrosa be granted marketing authorization, the Hungarian drug maker said in a statement on Monday. More »
A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo Dynavax Technologies Corp said on Monday the U.S. Food and Drug Administration had rejected the marketing applicatio... More »
A U.S. unit of British drug company BTG Plc pleaded guilty on Monday to improperly marketing its embolic device LC Bead, and will pay about $36 million to resolve its criminal and civil liability, the U.S. Department of Justice said. More »
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg/File Photo The U.S. Senate Judiciary Committee urged federal antitrust re... More »
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg/File Photo Three members of the U.S. Senate Judiciary Committee, ahead of... More »
Roche tablets are seen in this photo illustration shot January 18, 2016. REUTERS/Dado Ruvic/File Photo The spotlight on finding a cancer cure has spurred improvements in systems to collect and analyze oncology data, but efforts to track patients with other dis... More »
A person holds pharmaceutical tablets and capsules in this picture illustration taken in Ljubljana September 18, 2013. REUTERS/Srdjan Zivulovic By Magdalena MisLONDON (Thomson Reuters Foundation) – Essential medicines could be provided for as little as $1-$2 a... More »
Roche tablets are seen in this photo illustration shot in Zenica, Bosnia and Herzegovina, January 18, 2016. REUTERS/Dado Ruvic/File Photo Four patients have suffered serious adverse events in a clinical trial of an experimental hemophilia medicine from Roche, ... More »
Cancer drugmakers are cutting prices to ensure their medicines are used routinely on Britain’s National Health Service, following the overhaul of a cancer drug funding scheme, with Japan’s Eisai the latest to win approval. More »
U.S.-based bond funds charged back into the good graces of investors during the latest week, attracting $3.4 billion, Lipper data showed on Thursday. More »
Health insurer Cigna Corp has discontinued its policy of requiring doctors to seek authorization before treating opioid addicts, as part of a fight against an epidemic of opioid abuse, New York Attorney General Eric Schneiderman said on Friday. More »
A child is given a dose of polio vaccine at an immunisation health centre, in Maiduguri, Borno State, Nigeria, August 29, 2016. REUTERS/Afolabi Sotunde Two companies making vaccines to help the world eradicate polio are failing to produce enough, so many count... More »
